{"AllianceGenome": "9215", "HGNC": "9215", "MIM": "600494", "_id": "5454", "_version": 1, "accession": {"genomic": ["AB037475.1", "AB037476.1", "AL022395.2", "CH471051.2", "CP068272.2", "L37868.1", "NC_000006.12", "NC_060930.1", "Z31606.1"], "protein": ["AAB59611.1", "AAH51699.2", "BAG53090.1", "CAA77990.1", "EAW48491.1", "NP_005595.2", "P20265.4"], "rna": ["AK095588.1", "BC051699.1", "BQ423615.1", "BU183021.1", "DA491157.1", "NM_005604.4", "Z11933.1"], "translation": [{"protein": "CAA77990.1", "rna": "Z11933.1"}, {"protein": "BAG53090.1", "rna": "AK095588.1"}, {"protein": "NP_005595.2", "rna": "NM_005604.4"}, {"protein": "AAH51699.2", "rna": "BC051699.1"}]}, "alias": ["BRN2", "N-Oct3", "OCT7", "OTF-7", "OTF7", "POUF3", "brn-2", "oct-7"], "ensembl": {"gene": "ENSG00000184486", "protein": "ENSP00000329170", "transcript": "ENST00000328345", "translation": [{"protein": "ENSP00000329170", "rna": "ENST00000328345"}], "type_of_gene": "protein_coding"}, "entrezgene": "5454", "exons": [{"cdsend": 98836205, "cdsstart": 98834873, "chr": "6", "position": [[98834573, 98839458]], "strand": 1, "transcript": "NM_005604", "txend": 98839458, "txstart": 98834573}], "exons_hg19": [{"cdsend": 99284081, "cdsstart": 99282749, "chr": "6", "position": [[99282449, 99287334]], "strand": 1, "transcript": "NM_005604", "txend": 99287334, "txstart": 99282449}], "generif": [{"pubmed": 15024080, "text": "The results suggest that the high levels of Brn-2 expression observed in melanomas link BRAF signaling to increased proliferation."}, {"pubmed": 16858508, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 17163992, "text": "Rb induces a proliferative arrest and regulates Brn-2 expression in retinoblastoma cells"}, {"pubmed": 18829533, "text": "Brn-2 regulates invasiveness and directly represses Mitf expression."}, {"pubmed": 18923447, "text": "SOX9 and SOX10 but not BRN2 seem to be required for nestin expression in human melanoma."}, {"pubmed": 18996486, "text": "Expression and purification of full-length BRN2, a transcription factor involved in melanoma growth, are reported."}, {"pubmed": 19023125, "text": "Observational study and genome-wide association study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20337985, "text": "POU3F2 may regulate the properties of melanoma cells via autocrine KIT ligand signalling."}, {"pubmed": 21358674, "text": "links BRN2 as an activator and MITF as a repressor of the NOTCH pathway in melanoma cells. Loss of the BRN2-MITF axis in antisense-ablated cell lines decreased the melanoma sphere-forming capability and cell adhesion"}, {"pubmed": 21435193, "text": "a model for the apparent non-overlapping expression levels of BRN2 and MITF in melanoma, mediated by miR-211 expression."}, {"pubmed": 22988297, "text": "PI3K has a crucial role in regulating Brn-2 and Pax3 expression and neoplasm invasiveness, and it is a key determinant of melanoma subpopulation diversity."}, {"pubmed": 23069940, "text": "The present study investigated transcriptional regulation of CDH13 in melanoma. Found an inverse correlation between BRN2 and T-cadherin protein and transcript expression in melanoma."}, {"pubmed": 23358112, "text": "TTF1 expression in small-cell lung cancer is a cell lineage-specific phenomenon that involves the developing neural cell-specific homeoprotein BRN2."}, {"pubmed": 23530560, "text": "BRN2 is a higher level regulator than ASCL1 and ND1 and BRN2 might be involved in aggressiveness of small cell lung cancer."}, {"pubmed": 26833329, "text": "We show that POU3F2 lies downstreamof SIM1 and controls oxytocin expression in the hypothalamic neuroendocrine preoptic area. We show that this finding is consistent with the expression patterns of POU3F2 and related genes in the human brain."}, {"pubmed": 27271588, "text": "These findings not only shed light on the molecular mechanism of the anticancer properties of capsaicin, but also the transcription regulation of tNOX expression that may potentially explain how POU3F2 is associated with tumorigenesis."}, {"pubmed": 27784708, "text": "Re4sults show that BRN2 is: directly transcriptionally repressed by AR, required for the expression of terminal neuroendocrine markers and aggressive growth of castration-resistant prostate cancer (CRPC), and is highly expressed in human neuroendocrine prostate cancer and metastatic CRPC with low circulating PSA."}, {"pubmed": 28119061, "text": "Data indicate that NFIB protein increases EZH2 protein expression downstream of BRN2 protein, which further decreases MITF protein levels."}, {"pubmed": 28883623, "text": "These results suggest that the proliferative population within melanoma tumors express MITF, and both MITF and BRN2 are important for metastatic growth in vivo. This finding highlights the importance of BRN2 and MITF expression in development of melanoma metastasis."}, {"pubmed": 29549646, "text": "NTF3 is a novel target gene of POU3F2 and that the POU3F2/NTF3 pathway plays a role in the process of neuronal differentiation."}, {"pubmed": 29990501, "text": "CDKN2A suppresses the initiation of melanoma invasion through inhibition of BRN2."}, {"pubmed": 30545964, "text": "POU3F2 may be a key regulator of gene expression in this disease-associated gene coexpression module."}, {"pubmed": 30804224, "text": "BRN2 also suppresses an apoptosis-associated gene expression program to protect against UVB-, chemotherapy- and vemurafenib-induced apoptosis. Remarkably, BRN2 expression also correlates with a high single-nucleotide variation prevalence in human melanomas"}, {"pubmed": 31371344, "text": "BRN4 Is a Novel Driver of Neuroendocrine Differentiation in Castration-Resistant Prostate Cancer and Is Selectively Released in Extracellular Vesicles with BRN2."}, {"pubmed": 31551362, "text": "Study investigated super-enhancer profiles in lung squamous cell carcinoma (LUSC) and identified a novel subtype in which SOX2 and a neural transcription factor BRN2 have key roles in determining its distinctive differentiation state. BRN2 serves as an interacting partner for SOX2 in this novel subtype, instead of p63 in the classical subtype of LUSC."}, {"pubmed": 31881210, "text": "Unexpected High Levels of BRN2/POU3F2 Expression in Human Dermal Melanocytic Nevi."}, {"pubmed": 32929213, "text": "Transcription factor POU3F2 regulates TRIM8 expression contributing to cellular functions implicated in schizophrenia."}, {"pubmed": 33539344, "text": "Transcriptome-wide transmission disequilibrium analysis identifies novel risk genes for autism spectrum disorder."}, {"pubmed": 34140478, "text": "BRN2 is a non-canonical melanoma tumor-suppressor."}, {"pubmed": 34958806, "text": "Reciprocal Regulation of BRN2 and NOTCH1/2 Signaling Synergistically Drives Melanoma Cell Migration and Invasion."}, {"pubmed": 35398178, "text": "CircPOLR2A Promotes Proliferation and Impedes Apoptosis of Glioblastoma Multiforme Cells by Up-regulating POU3F2 to Facilitate SOX9 Transcription."}, {"pubmed": 36843258, "text": "Integrin alpha3 Mediates Stemness and Invasion of Glioblastoma by Regulating POU3F2."}, {"pubmed": 37207645, "text": "Monoallelic intragenic POU3F2 variants lead to neurodevelopmental delay and hyperphagic obesity, confirming the gene's candidacy in 6q16.1 deletions."}, {"pubmed": 38201271, "text": "CREB1 Facilitates GABAergic Neural Differentiation of Human Mesenchymal Stem Cells through BRN2 for Pain Alleviation and Locomotion Recovery after Spinal Cord Injury."}, {"pubmed": 38386071, "text": "RFX4 is an intrinsic factor for neuronal differentiation through induction of proneural genes POU3F2 and NEUROD1."}], "genomic_pos": {"chr": "6", "end": 98839458, "ensemblgene": "ENSG00000184486", "start": 98834574, "strand": 1}, "genomic_pos_hg19": {"chr": "6", "end": 99286660, "start": 99282580, "strand": 1}, "go": {"BP": [{"evidence": "IBA", "gocategory": "BP", "id": "GO:0006357", "qualifier": "involved_in", "term": "regulation of transcription by RNA polymerase II"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0006357", "qualifier": "involved_in", "term": "regulation of transcription by RNA polymerase II"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0007399", "qualifier": "involved_in", "term": "nervous system development"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0008284", "pubmed": 15024079, "qualifier": "acts_upstream_of_or_within", "term": "positive regulation of cell population proliferation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0008544", "qualifier": "involved_in", "term": "epidermis development"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0010629", "qualifier": "involved_in", "term": "negative regulation of gene expression"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0021799", "qualifier": "involved_in", "term": "cerebral cortex radially oriented cell migration"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0021869", "qualifier": "involved_in", "term": "forebrain ventricular zone progenitor cell division"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0021897", "qualifier": "involved_in", "term": "forebrain astrocyte development"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0021979", "qualifier": "involved_in", "term": "hypothalamus cell differentiation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0021985", "qualifier": "involved_in", "term": "neurohypophysis development"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0022011", "qualifier": "involved_in", "term": "myelination in peripheral nervous system"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0030182", "qualifier": "involved_in", "term": "neuron differentiation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0040018", "qualifier": "involved_in", "term": "positive regulation of multicellular organism growth"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0045595", "qualifier": "involved_in", "term": "regulation of cell differentiation"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0045944", "qualifier": "involved_in", "term": "positive regulation of transcription by RNA polymerase II"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0048663", "qualifier": "involved_in", "term": "neuron fate commitment"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0048665", "qualifier": "involved_in", "term": "neuron fate specification"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0048666", "qualifier": "involved_in", "term": "neuron development"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0050770", "qualifier": "involved_in", "term": "regulation of axonogenesis"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0061101", "qualifier": "involved_in", "term": "neuroendocrine cell differentiation"}], "CC": [{"evidence": "ISA", "gocategory": "CC", "id": "GO:0000785", "qualifier": "part_of", "term": "chromatin"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005654", "qualifier": "located_in", "term": "nucleoplasm"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005654", "qualifier": "located_in", "term": "nucleoplasm"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0005667", "qualifier": "part_of", "term": "transcription regulator complex"}], "MF": [{"category": "MF", "evidence": "IBA", "id": "GO:0000978", "qualifier": "enables", "term": "RNA polymerase II cis-regulatory region sequence-specific DNA binding"}, {"category": "MF", "evidence": "IBA", "id": "GO:0000981", "qualifier": "enables", "term": "DNA-binding transcription factor activity, RNA polymerase II-specific"}, {"category": "MF", "evidence": "ISA", "id": "GO:0000981", "qualifier": "enables", "term": "DNA-binding transcription factor activity, RNA polymerase II-specific"}, {"category": "MF", "evidence": "IEA", "id": "GO:0001228", "qualifier": "enables", "term": "DNA-binding transcription activator activity, RNA polymerase II-specific"}, {"category": "MF", "evidence": "ISS", "id": "GO:0003677", "qualifier": "enables", "term": "DNA binding"}, {"category": "MF", "evidence": "ISS", "id": "GO:0003700", "qualifier": "enables", "term": "DNA-binding transcription factor activity"}, {"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": 11029584, "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "IPI", "id": "GO:0042802", "pubmed": 11029584, "qualifier": "enables", "term": "identical protein binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:1990837", "pubmed": 28473536, "qualifier": "enables", "term": "sequence-specific double-stranded DNA binding"}]}, "homologene": {"genes": [[7955, 30397], [8364, 100486226], [9544, 694524], [9598, 472255], [9606, 5454], [9615, 481931], [9913, 783320], [10090, 18992], [10116, 29588]], "id": 4095}, "interpro": [{"desc": "POU-specific domain", "id": "IPR000327", "short_desc": "POU_dom"}, {"desc": "Homeobox domain", "id": "IPR001356", "short_desc": "Homeobox_dom"}, {"desc": "Homeobox-like domain superfamily", "id": "IPR009057", "short_desc": "Homeobox-like_sf"}, {"desc": "Lambda repressor-like, DNA-binding domain superfamily", "id": "IPR010982", "short_desc": "Lambda_DNA-bd_dom_sf"}, {"desc": "POU domain", "id": "IPR013847", "short_desc": "POU"}, {"desc": "POU-domain transcription factor, class 3", "id": "IPR016362", "short_desc": "TF_POU_3"}, {"desc": "Homeobox, conserved site", "id": "IPR017970", "short_desc": "Homeobox_CS"}], "ipi": ["IPI00300277", "IPI00759484", "IPI00759800"], "map_location": "6q16.1", "name": "POU class 3 homeobox 2", "other_names": ["POU domain, class 3, transcription factor 2", "brain-2", "brain-specific homeobox/POU domain protein 2", "nervous system-specific octamer-binding transcription factor N-Oct-3", "octamer-binding protein 7", "octamer-binding transcription factor 7"], "pantherdb": {"HGNC": "9215", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "101895", "ortholog_type": "LDO", "panther_family": "PTHR11636", "taxid": 10090, "uniprot_kb": "P31360"}, {"RGD": "61946", "ortholog_type": "LDO", "panther_family": "PTHR11636", "taxid": 10116, "uniprot_kb": "P56222"}, {"Ensembl": "ENSGALG00000031482", "ortholog_type": "O", "panther_family": "PTHR11636", "taxid": 9031, "uniprot_kb": "A0A3Q3ANA1"}, {"Gene": "POU5F3", "ortholog_type": "LDO", "panther_family": "PTHR11636", "taxid": 9031, "uniprot_kb": "A7Y7W2"}, {"ZFIN": "ZDB-GENE-980526-485", "ortholog_type": "O", "panther_family": "PTHR11636", "taxid": 7955, "uniprot_kb": "Q90270"}, {"ZFIN": "ZDB-GENE-980526-139", "ortholog_type": "O", "panther_family": "PTHR11636", "taxid": 7955, "uniprot_kb": "A2VD21"}, {"ZFIN": "ZDB-GENE-980526-370", "ortholog_type": "O", "panther_family": "PTHR11636", "taxid": 7955, "uniprot_kb": "P79746"}, {"ZFIN": "ZDB-GENE-980526-220", "ortholog_type": "O", "panther_family": "PTHR11636", "taxid": 7955, "uniprot_kb": "P56224"}, {"ZFIN": "ZDB-GENE-980526-140", "ortholog_type": "LDO", "panther_family": "PTHR11636", "taxid": 7955, "uniprot_kb": "P79745"}, {"WormBase": "WBGene00000431", "ortholog_type": "O", "panther_family": "PTHR11636", "taxid": 6239, "uniprot_kb": "P20268"}, {"FlyBase": "FBgn0086680", "ortholog_type": "O", "panther_family": "PTHR11636", "taxid": 7227, "uniprot_kb": "P16241"}], "uniprot_kb": "P20265"}, "pathway": {"reactome": [{"id": "R-HSA-1266738", "name": "Developmental Biology"}, {"id": "R-HSA-9619665", "name": "EGR2 and SOX10-mediated initiation of Schwann cell myelination"}, {"id": "R-HSA-9675108", "name": "Nervous system development"}, {"id": "R-HSA-9730414", "name": "MITF-M-regulated melanocyte development"}, {"id": "R-HSA-9824594", "name": "Regulation of MITF-M-dependent genes involved in apoptosis"}, {"id": "R-HSA-9856649", "name": "Transcriptional and post-translational regulation of MITF-M expression and activity"}, {"id": "R-HSA-9856651", "name": "MITF-M-dependent gene expression"}], "wikipathways": [{"id": "WP3584", "name": "MECP2 and Associated Rett Syndrome"}, {"id": "WP706", "name": "Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways"}]}, "pdb": "7XRC", "pfam": ["PF00046", "PF00157"], "pharmgkb": "PA33539", "pharos": {"target_id": 12845, "tdl": "Tbio"}, "pir": "S29334", "prosite": ["PS50071", "PS51179"], "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF168261", "relationship": "is"}, {"id": "GNF179167", "relationship": "is"}, {"id": "GNF190073", "relationship": "is"}, {"id": "GNF200979", "relationship": "is"}], "GNF_hs-Origene": {"id": "GNF037924", "relationship": "similar to"}, "GNF_mm+hs-MGC": {"id": "GNF011499", "relationship": "is"}, "NOVART_hs-genome_siRNA": [{"id": "GNF097143", "relationship": "is"}, {"id": "GNF136798", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000006.12", "NC_060930.1"], "protein": "NP_005595.2", "rna": "NM_005604.4", "translation": {"protein": "NP_005595.2", "rna": "NM_005604.4"}}, "reporter": {"HG-U133_Plus_2": ["207084_at", "242455_at"], "HG-U95Av2": "32327_at", "HTA-2_0": "TC06000828.hg.1", "HuEx-1_0": "2918388", "HuGene-1_1": "8121209", "HuGene-2_1": "17011175"}, "summary": "This gene encodes a member of the POU-III class of neural transcription factors. The encoded protein is involved in neuronal differentiation and enhances the activation of corticotropin-releasing hormone regulated genes. Overexpression of this protein is associated with an increase in the proliferation of melanoma cells. [provided by RefSeq, Mar 2012].", "symbol": "POU3F2", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1418762"}, "unigene": "Hs.182505", "uniprot": {"Swiss-Prot": "P20265"}, "wikipedia": {"url_stub": "POU3F2"}}